Keiichiro GENKA

Publication List Details

Period

1966 - 2003

Number

2

Co-Authors

Randomized Double-Blind Placebo-Controlled Trial of Bestatin in Patients With Resected Stage I Squamous-Cell Lung Carcinoma (2003)

Ichinose, Yukito, Genka, Keiichiro, Koike, Teruaki, Kato, Harubumi, Watanabe, Yoh, Mori, Takashi, ...

Background: Bestatin is a potent aminopeptidase inhibitor that has immunostimulant and antitumor activity. We conducted a prospective randomized, double-blind, placebo-controlled trial to determine...